Not everybody with blockages needs surgical intervention. Guidelines recommend against surgery in people with no symptoms and ...

Dear K.T.: Dexfenfluramine, aka Redux (also called "fen-phen" in combination with phentermine), was sold in the 1990s until ...

The findings from this single-center retrospective study compare outcomes between 2 groups of patients living with connective tissue disease–associated pulmonary arterial hypertension (CTD-PAH) ...

Pulmonary arterial hypertension (PAH) is a rare form of pulmonary hypertension. It occurs because progressive vascular ...

Pulmonary arterial hypertension is caused by narrowing of the blood vessels in the lungs. Learn how it happens, including ...

Hypertension does not directly cause dyspnoea; however it can lead to long-term effects on the heart and arteries ...

Three decades of data from the Global Burden of Disease Study were analyzed for trends in global, regional, and national ...

CHICAGO -- Adding sotatercept (Winrevair) to the treatment regimen for pulmonary arterial hypertension (PAH) in high-risk ...

The interim results of a phase 3 trial of Merck’s pulmonary arterial hypertension (PAH) treatment Winrevair were so ...

It’s not clear to me that you need to have this done in absence of symptoms. However, pulmonary hypertension is one condition where I refer my patients to an expert. (Both cardiologists and ...